34Y-31086-56226
2 vaccinations
2 coded responses
25 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 281 / NC
- Registered
- 2021-01-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-29
Registered in v-safe
-
2021-01-29
Dose 1 — Pfizer-BioNTech
- 2021-01-29
-
2021-01-30
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
-
2021-01-31
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
-
2021-02-13
Survey response — day 14, dose 1MedDRA: Disturbance in attention, Fatigue — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Fatigue and unable to concentrateMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-19
Dose 2 — Pfizer-BioNTech
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-03-21
- 2021-03-26
- 2021-04-02
- 2021-05-23
-
2021-08-20
Survey response — 6 months, dose 2MedDRA: Office visit, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Pregnancy · Healthcare visit (other): Office careMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-20
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-24
- 2022-02-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-29 | Pfizer-BioNTech | |
| 2 | 2021-02-19 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-08-20 | Unsuccessful |
Free text
Release 4 — day 14, dose 1
Symptoms: Fatigue and unable to concentrate
Release 9 — 6 months, dose 2
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | · | ✓ |
| SD | Disturbance in attention | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Pregnancy | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release